Little reminder gents (and ladies) of the trial:
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=372643
Secondary outcomes are function and pain measurements including VAS scores. Lets not forget on a 0-10 pain score, ATI saw improvements from 5.94 at the initial assessment to 0.76 at 12 months (P < .001) in its lateral epicondylitis study. The best measure of the success was for me grip strength scores improving over the 12-month follow-up from 20.17 kg [baseline] to 37.38 kg; P < .001):
https://journals.sagepub.com/doi/abs/10.1177/0363546513504285
Pretty compelling stuff for those who've ever endured tendinosis. I am very excited by these forthcoming results and only wish they'd including more secondary data - but too many studies get loaded down with multiplicity criticisms, so OCC have kept it simple with preferred orthcopedic composite measures.
- Forums
- ASX - By Stock
- J&J Partnership
Little reminder gents (and ladies) of the...
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
35.5¢ |
Change
-0.005(1.39%) |
Mkt cap ! $74.31M |
Open | High | Low | Value | Volume |
36.0¢ | 36.0¢ | 35.5¢ | $57.4K | 161.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 142866 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.5¢ | 27779 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 142866 | 0.350 |
2 | 38988 | 0.345 |
1 | 20000 | 0.340 |
1 | 2000 | 0.335 |
3 | 33821 | 0.330 |
Price($) | Vol. | No. |
---|---|---|
0.355 | 27779 | 1 |
0.360 | 111680 | 1 |
0.370 | 56794 | 4 |
0.375 | 24331 | 1 |
0.380 | 9391 | 3 |
Last trade - 12.37pm 08/07/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |